INKT
INKT clinical trials: MiNK Therapeutics, Inc.
Every trial on ClinicalTrials.gov where MiNK Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5
- Trials linked
- 4
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
INKT on the catalyst calendar · INKT registry changes
- Primary completion Jun 2027Sponsor estimatePhase 2NCT07615010A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute...MiNK Therapeutics · PneumoniaRecruitingINKTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 23, 2023ActualPhase 1NCT04582201A Clinical Trial to Evaluate the Safety of agenT-797 in COVID-19 Participants With ARDSMiNK Therapeutics · Respiratory Distress Syndrome, AdultCompletedINKTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2, 2024ActualPhase 1NCT05108623A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid TumorsMiNK Therapeutics · Tumor, SolidCompletedINKTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 13, 2023ActualPhase 1NCT04754100agenT-797 in Participants With Relapsed/Refractory Multiple MyelomaMiNK Therapeutics · Relapsed/Refractory Multiple MyelomaCompletedINKTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2029Sponsor estimatePhase 1NCT07869368BLinatumomab and iNKT in Relapsed B-Cell ALLUNC Lineberger Comprehensive Cancer Center · B-Cell ALLNot yet recruitingINKTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 5 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner